Use of two-stage test statistic in the two-period crossover trials

Biometrics

Volumn 53, Issue 3, 1997, Pages 1081-1091

  Wang, Sue Jane ^a   Hung, H M James ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Carryover; Maximum test; Monte Carlo; Significance level

Indexed keywords

STATISTICAL TESTS;

CARRYOVER; MAXIMUM TEST; MONTE CARLO; PARALLEL ANALYSIS; POWER; SIGNIFICANCE LEVELS; TEST PROCEDURES; TEST STATISTICS; TREATMENT EFFECTS; TYPE I ERROR RATE;

STATISTICS;

ARTICLE; CROSSOVER PROCEDURE; PARALLEL DESIGN; STATISTICAL ANALYSIS; STATISTICS; SYSTEM ANALYSIS;

EID: 0030864786     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533565     Document Type: Article

References (15)

1. Brown, B. W. (1980). The crossover experiment for clinical trials. Biometrics 36, 69-79.
2. Cox, D. R. (1958). Planning of Experiments. New York: Wiley.
3. Freeman, P. R. (1989). The performance of the two-stage analysis of two-treatment, two-period crossover trials. Statistics in Medicine 8, 1421-1432.
4. Grizzle, J. E. (1965). The two-period change-over design and its use in clinical trials. Biometrics 21, 469-480.
5. Grizzle, J. E. (1974). The two-period change-over design and its use in clinical trials (corrigenda). Biometrics 30, 727.
6. Hills, M. and Armitage, P. (1979). The two-period cross-over clinical trial. British Journal of Clinical Pharmacology 8, 7-20.
7. Hung, H. M. J. (1993). Two-stage tests for studying monotherapy and combination therapy in two-by-two factorial trials. Statistics in Medicine 12, 645-660.
8. Jones, B. and Kenward, M. G. (1989). Design and Analysis of Cross-Over Trials. Chapman and Hall: New York.
9. Kershner, R. P. and Federer, W. T. (1981). Two-treatment crossover designs for estimating a variety of effects. Journal of the American Statistical Association 76, 612-619.
10. Laska, E., Meisner, M., and Kushner, H. B. (1983). Optimal crosssover designs in the presence of carryover effects. Biometrics 39, 1087-1091.
11. Louis, T., Lavori, P., Bailar, J., and Polansky, M. (1984). Crossover and self-controlled designs in clinical research. The New England Journal of Medicine 31, 24-31.
12. Matthews, J. N. S. (1988). Recent developments in crossover designs. International Statistical Review 56, 117-127.
13. Patel, H. I. (1983). Use of baseline measurements in the two-period crossover design. Communications in Statistics 12, 2693-2712.
14. Willan, A. R. (1988). Using the maximum test statistic in the two-period crossover clinical trial. Biometrics 44, 211-218.
15. Willan, A. R. and Pater, J. L. (1986). Carryover and the two-period crossover clinical trial. Biometrics 42, 593-599.